Loading
companiesCompany
Treadwell Therapeutics
Treadwell Therapeutics is a Hong Kong-based biotechnology company running 3 late-stage cancer trials of CFI-402411, CFI-400945 and CFI-402257 in acute myeloid leukaemia, myelodysplastic syndromes / neoplasms and HR-positive / HER2-negative breast cancer.
Also called: Treadwell Therapeutics, Inc
Overview
Treadwell Therapeutics, based in Hong Kong, Hong Kong, is a biotechnology company. Treadwell Therapeutics is a clinical-stage, multi-modality oncology company developing small molecules, biologics and T-cell receptor therapies against novel cancer targets. On ClinicalTrials.gov it is the lead sponsor of 3 recruiting or active phase 2 and phase 3 interventional cancer trials, testing CFI-402411, CFI-400945 and CFI-402257 in acute myeloid leukaemia, myelodysplastic syndromes / neoplasms and HR-positive / HER2-negative breast cancer. The largest, NCT04521413 (Safety and Efficacy Study of CFI-402411 in Subjects With Advanced Solid Malignancies), plans to enrol 170 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry; company facts are from the official website.
Similar pages
- TrialA Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes
Shares Myelodysplastic syndromes / neoplasms (MDS), Acute myeloid leukaemia.
- PersonMarc H.G.P. Raaijmakers
Shares Myelodysplastic syndromes / neoplasms (MDS), Acute myeloid leukaemia.
- TrialStudy of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
Shares Myelodysplastic syndromes / neoplasms (MDS), Acute myeloid leukaemia.
- TreatmentARD103
Shares Myelodysplastic syndromes / neoplasms (MDS), Acute myeloid leukaemia.
- TrialFirst-in-human Study Aiming to Characterize the Safety, Tolerability, Pharmacokinetic and Preliminary Signs of Activity of ABD-3001 in Refractory or Relapsed AML and High Risk MDS Adult Patients
Shares Myelodysplastic syndromes / neoplasms (MDS), Acute myeloid leukaemia.
- TargetSLX4
Shares Myelodysplastic syndromes / neoplasms (MDS), Acute myeloid leukaemia.
- TrialPBSS1113 in Combination With Azacitidine to Treat Patients With AML/MDS
Shares Myelodysplastic syndromes / neoplasms (MDS), Acute myeloid leukaemia.
- TargetDDX41
Shares Myelodysplastic syndromes / neoplasms (MDS), Acute myeloid leukaemia.